Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « who »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
white < who < whole  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000017 (2020) Franziska Düver [Allemagne] ; Benedikt Wei Brich [Allemagne] ; Matthias Eyrich [Allemagne] ; Matthias Wölfl [Allemagne] ; Paul G. Schlegel [Allemagne] ; Verena Wiegering [Allemagne]Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysis
000035 (2020) Limin Li [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Mengyuan Xu [République populaire de Chine] ; Hongjuan Yu [République populaire de Chine] ; Chengfang Lv [République populaire de Chine] ; Fenglin Cao [République populaire de Chine] ; Zhenkun Wang [République populaire de Chine] ; Yueyue Fu [République populaire de Chine] ; Mingwen Zhang [République populaire de Chine] ; Hongbin Meng [République populaire de Chine] ; Xiaoqian Zhang [République populaire de Chine] ; Liqing Kang [République populaire de Chine] ; Zhuo Zhang [République populaire de Chine] ; Jinmei Li [République populaire de Chine] ; Jiawei Feng [République populaire de Chine] ; Xin Lian [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Jin Zhou [République populaire de Chine]Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients
000048 (2020) Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000051 (2020) Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000082 (2020) Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000115 (2020) Philip C. Robinson [Australie] ; Jinoos Yazdany [États-Unis]The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
000134 (2020) Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000166 (2020) Elyes Bouajina [Tunisie] ; Leith Zakraoui [Tunisie] ; Montassar Kchir [Tunisie] ; Samir Kochbati [Tunisie] ; Sofiene Baklouti [Tunisie]Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice.
000197 (2020) Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000199 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000204 (2020) Jennie H. Best [États-Unis] ; Steven C. Vlad [États-Unis] ; Lenore Tominna [États-Unis] ; Ibrahim Abbass [États-Unis]Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic.
000208 (2020) Natalia Maximova [Italie] ; Alessandra Maestro [Italie] ; Davide Zanon [Italie] ; Annalisa Marcuzzi [Italie]Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration
000218 (2020) Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
000225 (2020) Ali Rismanbaf [Iran]Potential Treatments for COVID-19; a Narrative Literature Review
000251 (2020) Simona Di Giambenedetto ; Arturo Ciccullo ; Alberto Borghetti ; Giovanni Gambassi [Italie] ; Francesco Landi [Italie] ; Elena Visconti ; Lorenzo Zileri Dal Verme ; Roberto Bernabei [Italie] ; Enrica Tamburrini ; Roberto Cauda ; Antonio Gasbarrini [Italie]Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
000255 (2020) Domenico Umberto De Rose [Italie] ; Fiammetta Piersigilli [Italie, Belgique] ; Maria Paola Ronchetti [Italie] ; Alessandra Santisi [Italie] ; Iliana Bersani [Italie] ; Andrea Dotta [Italie] ; Olivier Danhaive [Belgique] ; Cinzia Auriti [Italie]Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
000267 (2020) Emanuele Nicastri ; Nicola Petrosillo ; Tommaso Ascoli Bartoli ; Luciana Lepore ; Annalisa Mondi ; Fabrizio Palmieri ; Gianpiero D Ffizi ; Luisa Marchioni ; Silvia Murachelli ; Giuseppe Ippolito ; Andrea AntinoriNational Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 clinical management
000274 (2020) Meng Hsuan Kuo [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Chi-Hui Lee [Taïwan] ; Chien-Hsueh Tung [Taïwan] ; Kuo-Chih Tseng [Taïwan] ; Ning-Sheng Lai [Taïwan]Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
000278 (2020) Dimitrios A. Pappas [États-Unis] ; Taylor Blachley [États-Unis] ; Steve Zlotnick [États-Unis] ; Jennie Best [États-Unis] ; Kelechi Emeanuru [États-Unis] ; Joel M. Kremer [États-Unis]Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.
000286 (2020) Tiago Torres [Portugal] ; Luis Puig [Espagne]Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "who" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "who" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    who
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021